This move is archived. Current quotes and coverage live on the stock page.
Get CNVI alerts:
Conavi Medical Corp. faced a significant drop in stock value, raising concerns among investors.
Conavi Medical Corp. (CNVI.V) experienced a notable decline in its stock price yesterday, closing down by 9.09%. This drop has sparked discussions about the company's future and its recent performance in the market.
Advertisement
Conavi Medical Corp.
CNVI.V
CNVI.V
Conavi Medical Corp.
WealthAwesomeMarket cap
$22.77M
52W high
$0.70
52W low
$0.14
1W change
+3.13%
Analyst Price Targets
Based on analyst covering CNVI
Wall Street analysts forecast CNVI stock price to rise 506.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.00
+506.1% Upside
Current Price
C$0.17
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CNVI's historical volatility
30-Day Vol
115.1%
Annualized
90-Day Vol
94.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.14
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.16 | C$0.10 – C$0.23 |
| 60 trading days | C$0.15 | C$0.08 – C$0.26 |
| 90 trading days | C$0.14 | C$0.07 – C$0.27 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should closely monitor Conavi Medical's upcoming developments and market reactions, especially given the lack of recent news that could explain this downturn.
Conavi Medical Corp. stock fell 9.09% yesterday
The market capitalization of Conavi Medical Corp. is now approximately CA$20.7 million following the decline.
Bull case
If Conavi Medical secures FDA clearance for its Novasight Hybrid™ System, it could significantly boost revenue and restore market confidence.
Bear case
Ongoing uncertainty and a lack of positive news could further weaken investor confidence, potentially leading to more declines in stock value.
Market Reaction
Advertisement
The 9.09% drop in Conavi Medical's stock price yesterday reflects a broader concern among investors regarding the company's recent performance. With no significant news to explain the downturn, market sentiment appears to have soured, leading to increased selling pressure.
Future Outlook
Looking ahead, investors will be watching closely for any announcements related to Conavi Medical's product developments, particularly the anticipated U.S. launch of its Novasight Hybrid™ System. Positive news could help restore confidence and stabilize the stock price.
Understanding the Volatility
The volatility in Conavi Medical's stock underscores the risks associated with investing in smaller-cap companies. With a market cap of approximately CA$20.7 million, fluctuations can be more pronounced, making it crucial for investors to stay informed about market trends and company updates. For more details on Conavi Medical, visit our stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
